NCT07642232 Effects of Somatic Movement Therapy vs Core Strengthening in Premenstrual Syndrome
| NCT ID | NCT07642232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Premenstrual Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2025-05-05 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Premenstrual Syndrome (PMS) is a multifactorial disorder affecting women of reproductive age, causing physical discomfort, emotional instability, and reduced quality of life. This randomized clinical trial aims to compare the effects of Somatic Movement Therapy (SMT) and Core Strengthening Exercises (CSE) on symptom severity, perceived stress, and quality of life in 34 female participants aged 18-35 years diagnosed with PMS according to ACOG criteria. Group A will receive SMT, while Group B will perform CSE over a 6-week program. Outcomes will be measured using PSST, PSS-10, and WHOQOL-BREF, with data analyzed through SPSS version 27.
Eligibility Criteria
Inclusion Criteria: * Females aged 18 to 35 years. * Married and single women * Regular menstrual cycles (21-35 days) for the past 6 months. * Diagnosed with Premenstrual Syndrome (PMS) based on ACOG (American College of Obstetricians and Gynecologists) criteria Exclusion Criteria: * Diagnosed with PMDD or major psychiatric disorders (e.g., anxiety, depression). * Using hormonal contraceptives or mood/menstruation-altering medications * History of gynecological conditions (e.g., PCOS, endometriosis, fibroids). * Presence of chronic illnesses (e.g., diabetes, hypertension, CVD, thyroid disorders)
Contact & Investigator
Maryam Zahid, MS*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07642232 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Premenstrual Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07642232 currently recruiting?
Yes, NCT07642232 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07642232 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07642232 clinical trial?
NCT07642232 is sponsored by Riphah International University. The principal investigator is Maryam Zahid, MS* at Riphah International University. The trial plans to enroll 36 participants.